- Case Report
- Open Access
A disseminated variant of pancreatic serous cystadenoma causing obstructive jaundice, a very rare entity: a case report and review of the literature
© Al-Jiffry et al.; licensee BioMed Central Ltd. 2014
- Received: 5 November 2013
- Accepted: 14 October 2014
- Published: 22 October 2014
Microcystic adenoma or serous cystadenoma (SCA) is an uncommon tumor type, accounting for only 1–2% of pancreatic exocrine neoplasms. Usually unifocal, SCAs present as single, large, well-demarcated, multiloculated, cystic tumors, 1–25 cm in size.
A 73-year-old man initially presented with epigastric abdominal pain and was diagnosed with SCA involving the whole pancreas. Eleven months later, he presented with obstructive jaundice, and total pancreatectomy was performed. The removed tissue allowed histological verification of pancreatic SCA. Histopathological examination showed both microcysts and macrocysts, lined by cuboidal epithelium, with optically clear cytoplasm and the absence of detectable mitosis or necrosis.
Thus, although relatively rare, pancreatic SCA is one of the differential diagnoses of epigastric abdominal pain; we recommend early surgical intervention for symptomatic pancreatic SCA.
- Pancreatic cysts
- Disseminated variant
- Serous cystadenoma
- Obstructive jaundice
Microcystic adenoma or serous cystadenoma (SCA) of the pancreas is an uncommon, benign tumor that accounts for 1–2% of pancreatic exocrine neoplasms and 25% of cystic neoplasms . Their prevalence is increasing, primarily due to imaging technique improvements. These tumors are usually unifocal, mostly arising in the body and tail of the pancreas and are often incidentally detected. They present as single, large, well demarcated, and multiloculated cystic tumors, 1–25 cm in size. They are composed of cysts lined by epithelial cells that produce serous fluid and show ultrastructural evidence of centroacinar differentiation .
The World Health Organization (WHO) has subclassified these tumors into two groups, serous microcystic adenomas and serous oligocystic adenomas. The serous microcystic adenoma is a well-demarcated tumor composed of numerous small cysts arranged around a central stellate scar. The central stellate scar is a dense fibrous core within the tumor, which may be calcified and from which fibrous trabeculae radiate to the periphery. The serous oligocystic adenoma is an often ill-demarcated tumor composed of a few cysts with diameters of 1–2 cm. Serous cystic tumors showing larger cysts have been referred to as serous macrocystic adenomas . A third type, the disseminated variant (DV), has been recognized because of its rare involvement of the entire pancreas. In the DV, both of the previously described types are spread throughout the pancreas. Although DVs are rare, they are more commonly reported in association with Von Hippel-Lindau (VHL) disease . VHL disease, which is an autosomal dominant condition having variable penetrance, is characterized by central nervous system (CNS) and retinal hemangioblastomas, visceral cysts, pheochromocytomas, and renal cell carcinoma; pancreatic lesions are seen in approximately 56% of VHL patients . Criteria for the diagnosis of VHL include the presence of a CNS hemangioblastoma with at least one other VHL-type lesion in an individual or one VHL-type lesion in a family member if another family member has a CNS hemangioblastoma .
Here, we present a rare case of a pancreatic SCA involving the whole pancreas ( DV) that caused obstructive jaundice, with no association with VHL.
SCAs are benign cystic tumors composed of cuboidal epithelium and producing serous fluid . Although rare cases of serous cyst adenocarcinoma have been reported , the WHO reported that the prevalence of malignant pancreatic SCAs is 1–3% . This malignant variant is defined by the presence of metastases in extrapancreatic organs or tissues . In addition, the presence of invasion to the adjacent organs is considered a characteristic of malignancy . SCAs predominate in females in their sixth decade of life  and are asymptomatic in 33% of cases . Symptoms are frequently non-specific, with abdominal pain being the most common, occurring in 50–60% of all cases . The tumors rarely cause obstructive jaundice [6, 8–12] and are usually unifocal, situated in the body and tail of the pancreas, and are multiloculated and cystic in appearance. The present case can be classified as one of a multicentric serous tumor involving the entire pancreas with almost complete obliteration of pancreatic acini and ducts.
Patients with diffuse pancreatic serous cystadenoma (SCA)
Group (first author)
Compagno, 1978 
Shorten, 1986 
Core needle biopsy only
A & W, 2 yr
Kim, 1990 
A & W 3 months
Kim, 1997 
Pancreatic endocrine tumor
Yasuhara, 2002 
A & W 3 months
Tampi, 2006 
Agarwal, 2009 
Differentiation of SCAs from mucinous cystadenomas and pseudocysts is usually based on ultrasonography or CT findings. When the distinction is less clear, fine-needle aspiration of the cystic lesions for cytology and biochemical analysis of the fluid may help in establishing the diagnosis. On cytological analysis, periodic acid-Schiff stains of SCAs show abundant cytoplasmic glycogen, and stains for mucin are negative . Cells are cuboidal to polygonal in shape, without evident mitoses; cytological analysis is diagnostic in about 20% of cases . Biochemical analysis of cyst fluid may include tests for amylase and some tumor markers, such as carcinoembryonic antigen, NB/70K, CA 72–4, CA 125, CA 15–3 tissue polypeptide antigen, and pS2 protein [23, 24]. The amylase content of the fluid in SCAs is usually lower than the levels in pseudocysts and mucinous cystic tumors, and SCAs have lower levels of tumor markers compared with mucinous cystic tumors.
Most authors advise that asymptomatic patients be closely monitored, so long as potentially malignant cystic tumors, mainly mucinous cystadenoma or intraductal papillary mucinous tumor, can be definitively excluded. Surgical intervention is indicated for patients with symptomatic lesions and those with an uncertain diagnosis [25, 26]. Size of the cyst at presentation is still debatable since some reports indicate resection for cysts >4 cm and others do not .
Recently published guidelines for cystic pancreatic management suggest that resection should be considered for all symptomatic cases of SCA, for patients with cysts >4 cm, in case of presence of mural nodules, dilatation of main pancreatic duct >6 mm, increased serum levels of carbohydrate antigen (CA 19–9), or in case of rapid increase in size [28, 29].
In conclusion, SCAs of the pancreas are increasing in frequency of diagnosis because of advances in imaging techniques. The differentiation of SCAs from other cystic tumors, as well as from non-neoplastic cysts, is very important because of the great differences in the management of these different entities. This case highlights an extremely rare case of SCA involving the whole pancreas (DV) causing obstructive jaundice, without an association with VHL disease.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
- Owen DA, Kelly JK: Pathology of the Gall Bladder, Biliary Tract and Pancreas. 2001, Philadelphia: Saunders, 154-Google Scholar
- Alpert LC, Truong LD, Bossart MI, Spjut HJ: Microcystic adenoma (serous cystadenoma) of the pancreas. A study of 14 cases with immunohistochemical and electron-microscopic correlation. Am J Surg Pathol. 1988, 12: 251-263. 10.1097/00000478-198804000-00001.PubMedView ArticleGoogle Scholar
- Klöppel G, Solcia E, Longnecker DS:World Health Organization International Histological Classification of Tumors. Histologic Typing of Tumours of the Exocrine Pancreas. 1996, Berlin: Springer-Verlag, 2,View ArticleGoogle Scholar
- Hough DM, Stephens DH, Johnson CD, Binkovitz LA: Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. AJR Am J Roetgenol. 1994, 162: 1091-1094. 10.2214/ajr.162.5.8165988.View ArticleGoogle Scholar
- Bramis K, Petrou A, Papalambros A, Manzelli A, Mantonakis E, Brennan N, Felekouras E:Serous cystadenocarcinoma of the pancreas: report of a case and management reflections. World J Surg Oncol. 2012, 10: 51-10.1186/1477-7819-10-51. doi:10.1186/1477-7819-10-5110,PubMedPubMed CentralView ArticleGoogle Scholar
- Watanabe H, Ohtsubo K, Yamaguchi Y, Mouri H, Motoo Y, Noto M, Kitagawa H, Kayahara M, Ohta T, Gabata T, Sakamoto S, Sawabu N: Successful cystic fenestration for a macrocystic serous cystadenoma of the pancreas causing obstructive jaundice: report of a case. Surg Today. 2006, 36: 89-93.PubMedView ArticleGoogle Scholar
- Galanis C, Zamani A, Cameron JL, Campbell KA, Lillemoe KD, Caparrelli D, Chang D, Hruban RH, Yeo CJ: Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. J Gastrointest Surg. 2007, 11: 820-826. 10.1007/s11605-007-0157-4.PubMedView ArticleGoogle Scholar
- Compagno J, Oertel JE: Microcystic adenoma of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol. 1978, 69: 289-298.PubMedGoogle Scholar
- Horaguchi J, Fujita N, Kobayashi G, Noda Y, Kimura K, Ito K, Kobari M, Yamazaki T: Serous cystadenoma of the pancreas associated with obstructive jaundice. J Gastroenterol. 2003, 38: 501-506. 10.1007/s00535-002-1089-0.PubMedView ArticleGoogle Scholar
- Colović R, Grubor N, Micev M, Ranković V, Matić S: Latincić S [Serous microcystic adenoma of the head of the pancreas causing an obstructive jaundice]. [Article in Serbian]. Vojnosanit Pregl. 2008, 65: 839-842. 10.2298/VSP0811839C.PubMedView ArticleGoogle Scholar
- Kuwahara A, Koshitani T, Matsuda S, Takai T, Motoyoshi T, Yamashita Y, Kirishima T, Yoshinami N, Shintani H, Urata Y, Katsuma Y, Yoshikawa T: A case of serous cystadenoma of the pancrease associated with obstructive jaundice during long-term follow up. Nihon Shokakibyo Gakkai Zasshi. 2011, 108: 962-968.PubMedGoogle Scholar
- Kikuyama M: [On a case of serous cystadenoma causing obstructive jaundice]. Nihon Shokakibyo Gakkai Zasshi. 2012, 109: 263-[Article in Japanese]PubMedGoogle Scholar
- Truant S, Izgarevic D, Maunoury V, Buob D, Bulois P, Ernst O, Huet G, Zerbib P, Pruvot FR: Pancreatic Serous Cystadenoma with Compression of the Main Pancreatic Duct: An Unusual Entity. HPB Surgery. 2011, 2011: 574378-doi:10.1155/2011/574378PubMedPubMed CentralView ArticleGoogle Scholar
- Kim YH, Saini S, Sahani D, Hahn PF, Mueller PR, Auh YH:Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst. Radiographics. 2005, 25: 671-685. 10.1148/rg.253045104. Published online doi:10.1148/rg.253045104,PubMedView ArticleGoogle Scholar
- Shorten SD, Hart WR, Petras RE: Microcystic adenomas (serous cystadenomas) of the pancreas. A clinicopathologic investigation of eight cases with immunohistochemical and ultrastructural studies. Am J Surg Pathol. 1986, 10: 365-372. 10.1097/00000478-198606000-00001.PubMedView ArticleGoogle Scholar
- Kim YI, Seo JW, Suh JS, Lee KU, Choe KJ: Microcystic adenomas of the pancreas. Report of three cases with two of multicentric origin. Am J Clin Pathol. 1990, 94: 150-156.PubMedGoogle Scholar
- Kim YW, Park YK, Lee S, Park JH, Lee SM, Hong SW, Lee J, Yang MH: Pancreatic endocrine tumor admixed with a diffuse microcystic adenoma – a case report. J Korean Med Sci. 1997, 12: 469-472. 10.3346/jkms.19220.127.116.119.PubMedPubMed CentralView ArticleGoogle Scholar
- Yasuhara Y, Sakaida N, Uemura Y, Senzaki H, Shikata N, Tsubura A: Microcystic adenoma (glycogen-rich cystadenoma) of the pancreas: study of 11 cases showing clinicopathological and immunohistochemical correlations. Pathol Int. 2002, 52: 307-312. 10.1046/j.1440-1827.2002.01352.x.PubMedView ArticleGoogle Scholar
- Tampi C, Mullerpatan P, Shah R, Jagannath P, Zimmermann A: Microcystic serous cystadenoma of the pancreas: a report of two cases with one of diffuse presentation. Pancreatology. 2006, 6: 248-253. 10.1159/000092028.PubMedView ArticleGoogle Scholar
- Agarwal N, Kumar S, Dass J, Arora VK, Rathi V: Diffuse pancreatic serous cystadenoma associated with neuroendocrine carcinoma: a case report and review of literature. JOP. 2009, 10: 55-58.PubMedGoogle Scholar
- Laucirica R, Schwartz MR, Ramzy I: Fine needle aspiration of pancreatic cystic epithelial neoplasms. Acta Cytologica. 1992, 36: 881-886.PubMedGoogle Scholar
- Collins BT: Serous cystadenoma of the pancreas with endoscopic ultrasound fine needle aspiration biopsy and surgical correlation. Acta Cytol. 2013, 57: 241-251. 10.1159/000346911.PubMedView ArticleGoogle Scholar
- Hammel P, Levy P, Voitot H, Levy M, Vilgrain V, Zins M, Flejou JF, Molas G, Ruszniewski P, Bernades P: Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology. 1995, 108: 1230-1235. 10.1016/0016-5085(95)90224-4.PubMedView ArticleGoogle Scholar
- Yong WH, Southern JF, Pins MR, Warshaw AL, Compton CC, Lewandrowski KB: Cyst fluid NB/70K concentration and leukocyte esterase: two new markers for differentiating pancreatic serous tumors from pseudocysts. Pancreas. 1995, 10: 342-346. 10.1097/00006676-199505000-00004.PubMedView ArticleGoogle Scholar
- Tseng JF: Management of serous cystadenoma of the pancreas. J Gastrointest Surg. 2008, 12: 408-410. 10.1007/s11605-007-0360-3.PubMedView ArticleGoogle Scholar
- Wargo JA, Fernandez-del-Castillo C, Warshaw AL: Management of pancreatic serous cystadenomas. Adv Surg. 2009, 43: 23-34. 10.1016/j.yasu.2009.03.001.PubMedView ArticleGoogle Scholar
- Antonini F, Fuccio L, Fabbri C, Macarri G, Palazzo L: Management of serous cystic neoplasms of the pancreas. Expert Rev Gastroenterol Hepatol. 2014, 1: 1-11.Google Scholar
- Del Chiaro M1, Verbeke C, Salvia R, Klöppel G, Werner J, McKay C, Friess H, Manfredi R, Van Cutsem E, Löhr M, Segersvärd R, European Study Group on Cystic Tumours of the Pancreas:European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013, 45: 703-711. 10.1016/j.dld.2013.01.010.PubMedView ArticleGoogle Scholar
- Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G, Barresi L, Basso D, Bocus P, Calculli L, Capurso G, Canzonieri V, Casadei R, Crippa S, D'Onofrio M, Frulloni L, Fusaroli P, Manfredi G, Pacchioni D, Pasquali C, Rocca R, Ventrucci M, Venturini S, Villanacci V, Zerbi A, Italian Association of Hospital Gastroenterologists and Endoscopists; Italian Association for the Study of the Pancreas:Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014, 46: 479-493. 10.1016/j.dld.2013.12.019.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.